Carrier Screening Market Development Analysis, Share and Recent Trends By 2027
The market report study titled Global Carrier Screening Market published by Emergen Research
offers in-depth and comprehensive research describing the scope of the market
and market insights with an outlook to 2027. The report will include details
about potential opportunities, new projects, financial situations, constructive
business strategies, and an outlook on the industry forecast. The research
report provides an extensive analysis of the global Carrier Screening market
with a focus on key companies involved in the market and segmentation of the
market based on application, types, and regions. Advanced analytical tools such
as SWOT analysis and Porter’s Five Forces analysis along with detailed
diagrams, graphs, and figures, have been applied in this study.
Key
Highlights from the Report:
· The
carrier screening market is anticipated to grow at a substantial rate owing to
the convenience of simultaneously testing and screening for multiple genetic
disorders. The market growth can also be attributed to the soaring usage of
next-generation sequencing (NGS) technique to screen genetic disorders.
· During
the projected timeframe, DNA sequencing segment is forecast to occupy an
enormous share of the industry by contributing to the global revenue due to the
augmenting patient pool across Europe and North America. Moreover, the rising
awareness of the benefits of the initial diagnosis of acute diseases is
anticipated to drive the industry’s expansion.
· North
America is anticipated to command the market share,credited to the rising
number of tests performed for the analysis of genetic disorders. The regional
expansion can also be attributed to the accelerating upgradation of healthcare
infrastructure. Asia Pacific’s regional growth is estimated to snowball over
the estimated years, reporting a CAGR of 18.4% due to the soaring evidence of
genetic diseases and screening tests.
· Prominent
industry players include Luminex Corporation,Mount Sinai Genomics Inc.,
MedGenome Inc., Otogenetics Corporation, Thermo Fisher Scientific Inc.,
Corporation of America Holdings, Myriad Genetics Inc., Illumina Inc., Gene By
Gene Ltd., and Natera Inc., among others.
· Asuragen,
a molecular diagnostic firm, in 2019, unveiled the “AmplideX® PCR/CE SMN1/2
Plus Kit” that assists in the early screening of variants linked with the
duplication of the SMN1 gene. Usinga single PCR reaction, the technology
augments the efficiency and reduces the time taken for the results.
The report also provides an analysis of how
efficient is the company to achieve the set targets. The research report is
compiled using customer insights, marketing strategies, competitive landscape
analysis, and overall growth trend of the market. The Carrier Screening
industry is observing dynamic changed with several new players entering the
market. The competitive landscape data is provided by SWOT analysis of each
market player along with feasibility analysis, investment return analysis, and
Porter’s Five Forces analysis. The dominant and slow growing market segments
are also analyzed in the report to provide a complete understanding of each key
segment of the market.
To
know more about the report, visit @ https://www.emergenresearch.com/industry-report/carrier-screening-market
Thank you for reading our report. For further queries
on the report and customization, please connect with us.
Our team will ensure you get the report best suited for your needs.
Comments
Post a Comment